Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 82,500 | 58,000 | 30,200 | 22,800 | 185,400 |
| Depreciation Amortization | 174,600 | 135,000 | 89,300 | 44,600 | 163,800 |
| Income taxes - deferred | 2,200 | 3,200 | 800 | 100 | 26,400 |
| Accounts receivable | -14,300 | 10,100 | 3,700 | 12,800 | -13,600 |
| Accounts payable and accrued liabilities | -8,600 | -76,400 | -41,400 | -74,500 | 29,800 |
| Other Working Capital | 50,100 | -60,600 | -29,300 | -41,900 | 102,000 |
| Other Operating Activity | 100,900 | 139,400 | 110,600 | 61,700 | -17,700 |
| Operating Cash Flow | $387,400 | $208,700 | $163,900 | $25,600 | $476,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -87,000 | -48,500 | -25,900 | -6,800 | -115,400 |
| Net Acquisitions | -223,600 | -223,600 | -26,900 | N/A | -97,600 |
| Purchase Of Investment | -9,900 | -7,100 | -7,100 | -4,300 | N/A |
| Sale Of Investment | 14,300 | 11,500 | 11,500 | 11,500 | 9,200 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 21,900 |
| Investing Cash Flow | $-306,200 | $-267,700 | $-48,400 | $400 | $-181,900 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,650,000 | 1,650,000 | 1,650,000 | N/A | 315,000 |
| Debt Issued | N/A | -354,800 | N/A | N/A | 221,200 |
| Debt Repayment | -927,700 | -571,800 | -920,000 | -7,700 | -31,100 |
| Common Stock Issued | 19,800 | 16,600 | 12,600 | 6,000 | 47,900 |
| Dividend Paid | -842,200 | -798,600 | -769,800 | -25,600 | -799,300 |
| Other Financing Activity | -26,000 | -24,800 | -21,000 | -1,500 | -35,100 |
| Financing Cash Flow | $-126,100 | $-83,400 | $-48,200 | $-28,800 | $-281,400 |
| Beginning Cash Position | 288,800 | 288,800 | 288,800 | 288,800 | 276,000 |
| End Cash Position | 243,900 | 146,400 | 356,100 | 286,000 | 288,800 |
| Net Cash Flow | $-44,900 | $-142,400 | $67,300 | $-2,800 | $12,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 387,400 | 208,700 | 163,900 | 25,600 | 476,100 |
| Capital Expenditure | -124,300 | -80,800 | -46,000 | -17,700 | -137,500 |
| Free Cash Flow | 263,100 | 127,900 | 117,900 | 7,900 | 338,600 |